vs
Solventum（SOLV）与Take-Two Interactive（TTWO）财务数据对比。点击上方公司名可切换其他公司
Solventum的季度营收约是Take-Two Interactive的1.2倍（$2.0B vs $1.7B），Solventum净利率更高（3.2% vs -5.5%，领先8.6%），Take-Two Interactive同比增速更快（24.9% vs -3.7%），Take-Two Interactive自由现金流更多（$236.2M vs $32.0M），过去两年Take-Two Interactive的营收复合增速更高（10.2% vs -0.4%）
Solventum是一家总部位于美国的医疗健康企业，于2024年4月1日正式从全球知名多元化工业集团3M分拆后独立运营，继承了原3M旗下医疗板块的技术积累与业务资源，面向全球市场提供专业医疗相关产品及服务。
Take-Two Interactive是总部位于美国纽约的电子游戏控股企业，由瑞安·布兰特于1993年9月创立，在全球互动娱乐领域拥有较高影响力，业务覆盖游戏研发、发行与运营等核心环节。
SOLV vs TTWO — 直观对比
营收规模更大
SOLV
是对方的1.2倍
$1.7B
营收增速更快
TTWO
高出28.7%
-3.7%
净利率更高
SOLV
高出8.6%
-5.5%
自由现金流更多
TTWO
多$204.2M
$32.0M
两年增速更快
TTWO
近两年复合增速
-0.4%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.0B | $1.7B |
| 净利润 | $63.0M | $-92.9M |
| 毛利率 | 51.4% | 55.7% |
| 营业利润率 | 6.3% | -2.3% |
| 净利率 | 3.2% | -5.5% |
| 营收同比 | -3.7% | 24.9% |
| 净利润同比 | 103.2% | 25.8% |
| 每股收益（稀释后） | $0.37 | $-0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SOLVTTWO
| Q4 25 | $2.0B | $1.7B | ||
| Q3 25 | $2.1B | $1.8B | ||
| Q2 25 | $2.2B | $1.5B | ||
| Q1 25 | $2.1B | $1.6B | ||
| Q4 24 | $2.1B | $1.4B | ||
| Q3 24 | $2.1B | $1.4B | ||
| Q2 24 | $2.1B | $1.3B | ||
| Q1 24 | $2.0B | $1.4B |
净利润SOLVTTWO
| Q4 25 | $63.0M | $-92.9M | ||
| Q3 25 | $1.3B | $-133.9M | ||
| Q2 25 | $90.0M | $-11.9M | ||
| Q1 25 | $137.0M | $-3.7B | ||
| Q4 24 | $31.0M | $-125.2M | ||
| Q3 24 | $122.0M | $-365.5M | ||
| Q2 24 | $89.0M | $-262.0M | ||
| Q1 24 | $237.0M | $-2.9B |
毛利率SOLVTTWO
| Q4 25 | 51.4% | 55.7% | ||
| Q3 25 | 54.2% | 55.3% | ||
| Q2 25 | 54.4% | 62.8% | ||
| Q1 25 | 53.8% | 50.8% | ||
| Q4 24 | 53.9% | 55.9% | ||
| Q3 24 | 56.0% | 53.8% | ||
| Q2 24 | 54.6% | 57.6% | ||
| Q1 24 | 58.1% | 33.5% |
营业利润率SOLVTTWO
| Q4 25 | 6.3% | -2.3% | ||
| Q3 25 | 80.6% | -5.5% | ||
| Q2 25 | 9.9% | 1.4% | ||
| Q1 25 | 7.3% | -238.7% | ||
| Q4 24 | 6.6% | -9.7% | ||
| Q3 24 | 13.2% | -22.0% | ||
| Q2 24 | 11.7% | -13.8% | ||
| Q1 24 | 18.9% | -193.9% |
净利率SOLVTTWO
| Q4 25 | 3.2% | -5.5% | ||
| Q3 25 | 60.4% | -7.5% | ||
| Q2 25 | 4.2% | -0.8% | ||
| Q1 25 | 6.6% | -235.5% | ||
| Q4 24 | 1.5% | -9.2% | ||
| Q3 24 | 5.9% | -27.0% | ||
| Q2 24 | 4.3% | -19.6% | ||
| Q1 24 | 11.8% | -207.4% |
每股收益（稀释后）SOLVTTWO
| Q4 25 | $0.37 | $-0.50 | ||
| Q3 25 | $7.22 | $-0.73 | ||
| Q2 25 | $0.51 | $-0.07 | ||
| Q1 25 | $0.78 | $-21.27 | ||
| Q4 24 | $0.18 | $-0.71 | ||
| Q3 24 | $0.70 | $-2.08 | ||
| Q2 24 | $0.51 | $-1.52 | ||
| Q1 24 | $1.37 | $-17.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $878.0M | $2.4B |
| 总债务越低越好 | $5.0B | — |
| 股东权益账面价值 | $5.0B | $3.5B |
| 总资产 | $14.3B | $10.0B |
| 负债/权益比越低杠杆越低 | 1.00× | — |
8季度趋势，按日历期对齐
现金及短期投资SOLVTTWO
| Q4 25 | $878.0M | $2.4B | ||
| Q3 25 | $1.6B | $2.1B | ||
| Q2 25 | $492.0M | $2.0B | ||
| Q1 25 | $534.0M | $1.5B | ||
| Q4 24 | $762.0M | $1.2B | ||
| Q3 24 | $772.0M | $879.6M | ||
| Q2 24 | $897.0M | $1.1B | ||
| Q1 24 | $996.0M | $776.0M |
总债务SOLVTTWO
| Q4 25 | $5.0B | — | ||
| Q3 25 | $5.1B | — | ||
| Q2 25 | $7.8B | — | ||
| Q1 25 | $7.9B | — | ||
| Q4 24 | $8.0B | — | ||
| Q3 24 | $8.1B | — | ||
| Q2 24 | $8.3B | — | ||
| Q1 24 | $8.3B | — |
股东权益SOLVTTWO
| Q4 25 | $5.0B | $3.5B | ||
| Q3 25 | $5.0B | $3.4B | ||
| Q2 25 | $3.6B | $3.5B | ||
| Q1 25 | $3.3B | $2.1B | ||
| Q4 24 | $3.0B | $5.7B | ||
| Q3 24 | $3.2B | $5.8B | ||
| Q2 24 | $2.9B | $6.0B | ||
| Q1 24 | $3.9B | $5.7B |
总资产SOLVTTWO
| Q4 25 | $14.3B | $10.0B | ||
| Q3 25 | $14.0B | $10.1B | ||
| Q2 25 | $15.1B | $9.7B | ||
| Q1 25 | $14.5B | $9.2B | ||
| Q4 24 | $14.5B | $12.7B | ||
| Q3 24 | $14.7B | $13.1B | ||
| Q2 24 | $14.6B | $12.9B | ||
| Q1 24 | $14.7B | $12.2B |
负债/权益比SOLVTTWO
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.14× | — | ||
| Q1 25 | 2.43× | — | ||
| Q4 24 | 2.71× | — | ||
| Q3 24 | 2.54× | — | ||
| Q2 24 | 2.90× | — | ||
| Q1 24 | 2.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $95.0M | $305.2M |
| 自由现金流经营现金流 - 资本支出 | $32.0M | $236.2M |
| 自由现金流率自由现金流/营收 | 1.6% | 13.9% |
| 资本支出强度资本支出/营收 | 3.2% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.51× | — |
| 过去12个月自由现金流最近4个季度 | $-10.0M | $487.8M |
8季度趋势，按日历期对齐
经营现金流SOLVTTWO
| Q4 25 | $95.0M | $305.2M | ||
| Q3 25 | $76.0M | $128.4M | ||
| Q2 25 | $169.0M | $-44.7M | ||
| Q1 25 | $29.0M | $279.0M | ||
| Q4 24 | $219.0M | $-4.8M | ||
| Q3 24 | $169.0M | $-128.4M | ||
| Q2 24 | $355.0M | $-191.0M | ||
| Q1 24 | $442.0M | $-8.9M |
自由现金流SOLVTTWO
| Q4 25 | $32.0M | $236.2M | ||
| Q3 25 | $-21.0M | $96.5M | ||
| Q2 25 | $59.0M | $-69.8M | ||
| Q1 25 | $-80.0M | $224.9M | ||
| Q4 24 | $92.0M | $-48.2M | ||
| Q3 24 | $76.0M | $-165.2M | ||
| Q2 24 | $297.0M | $-226.1M | ||
| Q1 24 | $340.0M | $-55.1M |
自由现金流率SOLVTTWO
| Q4 25 | 1.6% | 13.9% | ||
| Q3 25 | -1.0% | 5.4% | ||
| Q2 25 | 2.7% | -4.6% | ||
| Q1 25 | -3.9% | 14.2% | ||
| Q4 24 | 4.4% | -3.5% | ||
| Q3 24 | 3.7% | -12.2% | ||
| Q2 24 | 14.3% | -16.9% | ||
| Q1 24 | 16.9% | -3.9% |
资本支出强度SOLVTTWO
| Q4 25 | 3.2% | 4.1% | ||
| Q3 25 | 4.6% | 1.8% | ||
| Q2 25 | 5.1% | 1.7% | ||
| Q1 25 | 5.3% | 3.4% | ||
| Q4 24 | 6.1% | 3.2% | ||
| Q3 24 | 4.5% | 2.7% | ||
| Q2 24 | 2.8% | 2.6% | ||
| Q1 24 | 5.1% | 3.3% |
现金转化率SOLVTTWO
| Q4 25 | 1.51× | — | ||
| Q3 25 | 0.06× | — | ||
| Q2 25 | 1.88× | — | ||
| Q1 25 | 0.21× | — | ||
| Q4 24 | 7.06× | — | ||
| Q3 24 | 1.39× | — | ||
| Q2 24 | 3.99× | — | ||
| Q1 24 | 1.86× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
TTWO
暂无分部数据
